4//SEC Filing
Wilson Marc 4
Accession 0000950170-24-084328
CIK 0001658247other
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 5:14 PM ET
Size
8.3 KB
Accession
0000950170-24-084328
Insider Transaction Report
Form 4
Wilson Marc
CFO
Transactions
- Exercise/Conversion
Common Stock
2024-07-15$20.02/sh+25,000$500,500→ 136,092 total - Exercise/Conversion
Stock option (Right to Buy)
2024-07-15−25,000→ 66,000 totalExercise: $20.02Exp: 2032-02-29→ Common Stock (25,000 underlying) - Sale
Common Stock
2024-07-15$55.00/sh−25,000$1,375,000→ 111,092 total
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]1/48th of the shares subject to the option vested on March 31, 2022, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
Documents
Issuer
Crinetics Pharmaceuticals, Inc.
CIK 0001658247
Entity typeother
Related Parties
1- filerCIK 0001702265
Filing Metadata
- Form type
- 4
- Filed
- Jul 16, 8:00 PM ET
- Accepted
- Jul 17, 5:14 PM ET
- Size
- 8.3 KB